Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Antidepressants and health-related quality of life (HRQoL) for patients with depression: Analysis of the medical expenditure panel survey from the United States
Omar A. Almohammed, Abdulaziz Alsalem, Abdullah Almangour, et al.
PLoS ONE (2022) Vol. 17, Iss. 4, pp. e0265928-e0265928
Open Access | Times Cited: 43

Showing 1-25 of 43 citing articles:

Single-Dose Psilocybin Treatment for Major Depressive Disorder
Charles L. Raison, Gerard Sanacora, Joshua D. Woolley, et al.
JAMA (2023) Vol. 330, Iss. 9, pp. 843-843
Open Access | Times Cited: 217
Is AI the Future of Mental Healthcare?
Francesca Minerva, Alberto Giubilini
Topoi (2023) Vol. 42, Iss. 3, pp. 809-817
Open Access | Times Cited: 53
A randomized controlled trial of a therapist-guided online intervention for depressed adults and its utility as an adjunctive to antidepressants and psychotherapy
Manuel Heinrich, Pavle Zagorscak, Christina Kampisiou, et al.
BMC Psychiatry (2025) Vol. 25, Iss. 1
Open Access | Times Cited: 1
High-intensity interval training versus moderate-intensity continuous training on patient quality of life in cardiovascular disease: a systematic review and meta-analysis
Haohan Yu, Xudong Zhao, Xiaoxia Wu, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 23
Relationship between depression, anxiety, stress, and health-related quality of life in adults with and without chronic diseases: A cross-sectional study
Young Hui Hwang, Jihyun Oh
Medicine (2024) Vol. 103, Iss. 2, pp. e36967-e36967
Open Access | Times Cited: 6
The magnitude and sustainability of treatment benefit of zuranolone on function and well-being as assessed by the SF-36 in adult patients with MDD and PPD: An integrated analysis of 4 randomized clinical trials
Anita H. Clayton, Ellison Suthoff, Rakesh K. Jain, et al.
Journal of Affective Disorders (2024) Vol. 351, pp. 904-914
Open Access | Times Cited: 5
Case Studies

Cambridge University Press eBooks (2025), pp. 251-355
Closed Access
Case Study: Antidepressant Medications

Cambridge University Press eBooks (2025), pp. 317-338
Closed Access
Antidepressants and quality of life in patients with major depressive disorder – Systematic review and meta‐analysis of double‐blind, placebo‐controlled RCTs
Teresa Wiesinger, Stefanie Kremer, Tom Bschor, et al.
Acta Psychiatrica Scandinavica (2023) Vol. 147, Iss. 6, pp. 545-560
Open Access | Times Cited: 15
Ketamine and Major Ketamine Metabolites Function as Allosteric Modulators of Opioid Receptors
Ivone Gomes, Achla Gupta, Elyssa B. Margolis, et al.
Molecular Pharmacology (2024) Vol. 106, Iss. 5, pp. 240-252
Closed Access | Times Cited: 4
Design, synthesis of 1,2,4-triazine derivatives as antidepressant and antioxidant agents: In vitro, in vivo and in silico studies
Rohit Pal, Bhupinder Kumar, Guruubasavaraja Swamy P M, et al.
Bioorganic Chemistry (2022) Vol. 131, pp. 106284-106284
Closed Access | Times Cited: 19
Is cognitive behavioral therapy more effective than pharmacotherapy for binge spectrum disorders? A systematic review and meta-analysis
Myrto Samara, Niki Michou, Andreas S. Lappas, et al.
Australian & New Zealand Journal of Psychiatry (2024) Vol. 58, Iss. 4, pp. 308-319
Open Access | Times Cited: 3
Glutamatergic Modulators for Major Depression from Theory to Clinical Use
Roger S. McIntyre, Rakesh Jain
CNS Drugs (2024) Vol. 38, Iss. 11, pp. 869-890
Open Access | Times Cited: 3
Symptomatic versus disease‐modifying effects of psychiatric drugs
S. Nassir Ghaemi
Acta Psychiatrica Scandinavica (2022) Vol. 146, Iss. 3, pp. 251-257
Closed Access | Times Cited: 17
Leveraging big data for causal understanding in mental health: a research framework
Jennifer Jane Newson, Jerzy Bala, Jay N. Giedd, et al.
Frontiers in Psychiatry (2024) Vol. 15
Open Access | Times Cited: 3
The Montreal model: an integrative biomedical-psychedelic approach to ketamine for severe treatment-resistant depression
Nicolas Garel, Jessica Drury, Julien Thibault Lévesque, et al.
Frontiers in Psychiatry (2023) Vol. 14
Open Access | Times Cited: 7
The effect of brief exposure to virtual nature on mental wellbeing in adolescents
Matthew Owens, Hannah L. I. Bunce
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 7
Effects and neural mechanisms of different physical activity on major depressive disorder based on cerebral multimodality monitoring: a narrative review
Jian Guan, Yan Sun, Yiming Fan, et al.
Frontiers in Human Neuroscience (2024) Vol. 18
Open Access | Times Cited: 2
The Untapped Potential of Ginsenosides and American Ginseng Berry in Promoting Mental Health via the Gut–Brain Axis
Tristan St-Laurent, Riadh Hammami
Nutrients (2022) Vol. 14, Iss. 12, pp. 2523-2523
Open Access | Times Cited: 11
Attitudes toward and patterns of medication use among people with serious mental illness: There’s more than meets the eye
Maia Asher, David Roe, Ilanit Hasson‐Ohayon
Frontiers in Psychiatry (2023) Vol. 14
Open Access | Times Cited: 4
Transcranial Focused Ultrasound Targeting the Default Mode Network for the Treatment of Depression
Jessica N. Schachtner, Jacob Dahill-Fuchel, Katja E. Allen, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Can Lifestyle Medicine Improve Global Mental Health?
Steven G. Sugden, Gia Merlo, Sam Manger
(2024) Vol. 1, Iss. 1
Open Access | Times Cited: 1
Predictors of Changes in Quality of Life of Patients with Major Depressive Disorder—A Prospective Naturalistic 3-Month Follow-Up Study
Vlad Dionisie, Maria Gabriela Puiu, Mirela Manea, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 14, pp. 4628-4628
Open Access | Times Cited: 3
Changes in treatment outcomes in patients undergoing an integrated psychosomatic inpatient treatment: Results from a cohort study
Monika Sadlonova, Julia Katharina Löser, Christopher M. Celano, et al.
Frontiers in Psychiatry (2022) Vol. 13
Open Access | Times Cited: 4
Neural correlates of psychodynamic and non-psychodynamic therapies in different clinical populations through fMRI: A meta-analysis and systematic review
Nicoletta Cera, Jéssica Monteiro, Roberto Esposito, et al.
Frontiers in Human Neuroscience (2022) Vol. 16
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top